FMP
BB Biotech AG
BBZA.DE
XETRA
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
28.65 EUR
-0.3 (-1.05%)
About
ceo
Dr. Daniel Koller Ph.D.
sector
Healthcare
industry
Biotechnology
exchange
XETRA
Description
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
CIK
N/A
ISIN
CH0038389992
CUSIP
N/A
Address
Seestrasse 16
Phone
41 44 267 67 00
Country
CH
Employee
10
IPO Date
Jun 29, 2020
Key Executives
